UP!
| 2016-07-04 | Reiterated Rating | Jefferies Group | Buy | |
| 2016-06-27 | Reiterated Rating | Credit Suisse | Buy | |
| 2016-06-27 | Reiterated Rating | Credit Suisse Group AG | Buy | |
| 2016-06-20 | Downgrade | Morgan Stanley | Equal Weight to Underweight | $67.00 to $70.00 |
| 2016-06-16 | Initiated Coverage | Sanford C. Bernstein | Underperform | $68.00 |
| 2016-06-15 | Reiterated Rating | Cowen and Company | Positive | $83.00 |
| 2016-06-07 | Reiterated Rating | Bank of America | Neutral | $82.00 |
| 2016-06-07 | Reiterated Rating | Bank of America Corp. | Neutral | $82.00 |
| 2016-06-06 | Reiterated Rating | Morgan Stanley | Hold | |
| 2016-06-04 | Reiterated Rating | Credit Suisse | Buy | |
| 2016-06-01 | Reiterated Rating | Wedbush | Neutral | |
| 2016-05-24 | Reiterated Rating | Citigroup Inc. | Buy | |
| 2016-04-27 | Reiterated Rating | Leerink Swann | Hold | |
| 2016-04-27 | Lower Price Target | FBR & Co. | Mkt Perform | $90.00 to $75.00 |
| 2016-04-27 | Lower Price Target | FBR & Co | Mkt Perform | $90.00 to $75.00 |
| 2016-04-26 | Boost Price Target | Credit Suisse | Outperform | $83.00 to $85.00 |
| 2016-04-17 | Reiterated Rating | Argus | Hold | |
| 2016-04-12 | Reiterated Rating | Deutsche Bank | Sell | |
| 2016-04-12 | Reiterated Rating | Deutsche Bank AG | Sell | |
| 2016-04-07 | Reiterated Rating | Credit Suisse | Buy | $83.00 |
| 2016-04-04 | Upgrade | Cowen and Company | Market Perform to Outperform | $76.00 to $80.00 |
| 2016-03-27 | Reiterated Rating | Oppenheimer | Market Perform | |
| 2016-03-27 | Reiterated Rating | Oppenheimer Holdings Inc. | Market Perform | |
| 2016-03-23 | Reiterated Rating | Leerink Swann | Market Perform | $80.00 to $65.00 |
| 2016-03-23 | Reiterated Rating | Credit Suisse | Buy | $83.00 |
| 2016-03-22 | Reiterated Rating | Morgan Stanley | Hold | $67.00 |
| 2016-03-22 | Reiterated Rating | FBR & Co. | Market Perform | $90.00 |
| 2016-03-22 | Reiterated Rating | Deutsche Bank | Sell | $61.00 |
| 2016-03-21 | Lower Price Target | Evercore ISI | $74.00 to $70.00 | |
| 2016-03-18 | Lower Price Target | Evercore ISI | Hold | $74.00 to $70.00 |
| 2016-03-18 | Reiterated Rating | William Blair | Buy | |
| 2016-03-15 | Reiterated Rating | Morgan Stanley | Equal Weight | $73.00 |
| 2016-03-15 | Initiated Coverage | Credit Suisse | Outperform | $83.00 |
| 2016-03-01 | Downgrade | Mizuho | Buy to Neutral | $93.00 to $77.00 |
| 2016-02-22 | Downgrade | Deutsche Bank | Hold to Sell | $93.00 to $61.00 |
| 2016-02-22 | Downgrade | Credit Suisse | Hold to Sell | $61.00 |
| 2016-02-18 | Boost Price Target | Barclays | Overweight | $85.00 to $102.00 |
| 2016-02-18 | Reiterated Rating | FBR & Co. | Market Perform | $90.00 |
| 2016-02-18 | Lower Price Target | Goldman Sachs | Neutral | $82.00 to $74.00 |
| 2016-02-18 | Lower Price Target | Goldman Sachs Group Inc. | Neutral | $82.00 to $74.00 |
| 2016-02-18 | Boost Price Target | Barclays PLC | Overweight | $85.00 to $102.00 |
| 2016-02-17 | Reiterated Rating | Maxim Group | Buy | $109.00 to $95.00 |
| 2016-02-17 | Lower Price Target | Robert W. Baird | Neutral | $85.00 to $80.00 |
| 2016-02-10 | Reiterated Rating | Deutsche Bank | Hold | |
| 2016-01-29 | Lower Price Target | Citigroup Inc. | Buy | $109.00 to $92.00 |
| 2016-01-22 | Reiterated Rating | Leerink Swann | Hold | |
| 2016-01-21 | Downgrade | Morgan Stanley | Overweight to Equal Weight | $92.00 to $74.00 |
| 2016-01-19 | Downgrade | Leerink Swann | Outperform to Market Perform | $95.00 to $80.00 |
| 2016-01-17 | Reiterated Rating | FBR & Co. | Hold | |
| 2016-01-15 | Lower Price Target | Robert W. Baird | Neutral | $92.00 to $85.00 |
| 2016-01-14 | Reiterated Rating | Deutsche Bank | Hold | $96.00 to $93.00 |
| 2016-01-13 | Reiterated Rating | Leerink Swann | Positive | $95.00 |
| 2016-01-13 | Reiterated Rating | Mizuho | Buy | $101.00 to $93.00 |
| 2015-12-29 | Reiterated Rating | Citigroup Inc. | Buy | |
| 2015-12-29 | Reiterated Rating | Oppenheimer | Hold | |
| 2015-12-28 | Reiterated Rating | FBR & Co. | Hold | |
| 2015-12-28 | Reiterated Rating | Leerink Swann | Buy | |
| 2015-12-23 | Reiterated Rating | Citigroup Inc. | Buy | $109.00 |
| 2015-12-23 | Boost Price Target | BMO Capital Markets | Market Perform | $94.00 |
| 2015-12-22 | Reiterated Rating | Leerink Swann | Buy | |
| 2015-12-22 | Reiterated Rating | FBR & Co. | Hold | $90.00 |
| 2015-11-29 | Reiterated Rating | JPMorgan Chase & Co. | Buy | $105.00 |
| 2015-11-23 | Reiterated Rating | JPMorgan Chase & Co. | Buy | |
| 2015-11-16 | Reiterated Rating | Leerink Swann | Buy | |
| 2015-10-29 | Reiterated Rating | Maxim Group | Buy | |
| 2015-10-28 | Lower Price Target | Robert W. Baird | $94.00 to $92.00 | |
| 2015-10-08 | Lower Price Target | Robert W. Baird | Neutral | $94.00 |
| 2015-10-05 | Lower Price Target | Leerink Swann | Outperform | $105.00 to $95.00 |
| 2015-09-13 | Reiterated Rating | Deutsche Bank | Hold | $96.00 |
| 2015-09-11 | Reiterated Rating | Mizuho | Buy | $101.00 |
| 2015-09-11 | Reiterated Rating | Leerink Swann | Outperform | $105.00 |
| 2015-09-11 | Reiterated Rating | William Blair | Outperform | |
| 2015-09-09 | Reiterated Rating | Evercore ISI | Hold | $97.00 |
| 2015-07-30 | Boost Price Target | RBC Capital | Outperform | $87.00 to $96.00 |
| 2015-07-30 | Boost Price Target | Royal Bank Of Canada | Outperform | $87.00 to $96.00 |
| 2015-07-29 | Reiterated Rating | Oppenheimer | Market Perform | |
| 2015-07-16 | Initiated Coverage | Mizuho | Buy | $98.00 to $101.00 |
| 2015-07-02 | Reiterated Rating | Barclays | Overweight | $102.00 |
| 2015-06-24 | Set Price Target | Jefferies Group | Buy | $98.00 |
| 2015-06-23 | Reiterated Rating | Deutsche Bank | Hold | $95.00 |
| 2015-06-18 | Initiated Coverage | Stephens | Market Perform | |
| 2015-06-17 | Initiated Coverage | Oppenheimer | Market Perform | |
| 2015-06-15 | Reiterated Rating | Deutsche Bank | Hold | $96.00 to $95.00 |
| 2015-06-02 | Reiterated Rating | Morgan Stanley | Buy | |
| 2015-06-01 | Reiterated Rating | Cowen and Company | Neutral | $86.00 |
| 2015-06-01 | Downgrade | Raymond James | Outperform to Market Perform | |
| 2015-06-01 | Downgrade | Raymond James Financial Inc. | Outperform to Market Perform | |
| 2015-05-19 | Initiated Coverage | Robert W. Baird | Neutral | $94.00 |
| 2015-04-29 | Set Price Target | Leerink Swann | Outperform to Buy | $90.00 to $95.00 |
| 2015-03-10 | Boost Price Target | RBC Capital | Outperform | $82.00 to $87.00 |
| 2015-02-26 | Boost Price Target | Deutsche Bank | Hold | $92.00 to $96.00 |
| 2015-02-26 | Boost Price Target | Leerink Swann | Outperform | $85.00 to $90.00 |
| 2015-02-24 | Boost Price Target | Maxim Group | Buy | $90.00 to $109.00 |
| 2015-02-24 | Reiterated Rating | Oppenheimer | Outperform | $88.00 |
| 2015-02-24 | Boost Price Target | Mizuho | Buy | $94.00 to $98.00 |
| 2015-01-28 | Downgrade | FBR & Co. | Outperform to Market Perform | |
| 2015-01-21 | Initiated Coverage | Stephens | Equal Weight | |
| 2015-01-08 | Boost Price Target | Barclays | Overweight | $94.00 to $102.00 |
| 2015-01-08 | Boost Price Target | JPMorgan Chase & Co. | Overweight | $89.00 to $100.00 |
| 2015-01-08 | Boost Price Target | Mizuho | Buy | $82.00 to $94.00 |
| 2014-12-16 | Boost Price Target | Oppenheimer | Outperform | $82.00 to $88.00 |
| 2014-12-04 | Reiterated Rating | Deutsche Bank | Hold | $76.00 to $88.00 |
| 2014-12-03 | Boost Price Target | Barclays | Overweight | $83.00 to $94.00 |
| 2014-10-30 | Reiterated Rating | Citigroup Inc. | Buy | $84.00 to $86.00 |
| 2014-10-30 | Boost Price Target | RBC Capital | Outperform | $73.00 to $82.00 |
| 2014-10-30 | Reiterated Rating | Credit Suisse | Outperform | $80.00 to $83.00 |
| 2014-09-11 | Downgrade | Goldman Sachs | Buy to Neutral | $75.05 to $75.00 |
| 2014-07-31 | Lower Price Target | Cowen and Company | Market Perform | $77.00 to $76.00 |
| 2014-07-30 | Lower Price Target | Jefferies Group | Buy | $86.00 to $80.00 |
| 2014-07-23 | Reiterated Rating | FBR & Co. | Outperform | $79.00 to $74.00 |
| 2014-07-23 | Downgrade | Cleveland Research | Buy to Neutral | |
| 2014-06-04 | Boost Price Target | Leerink Swann | Outperform | $80.00 to $85.00 |
| 2014-06-02 | Downgrade | Cowen and Company | Outperform to Market Perform | $79.00 to $77.00 |
| 2014-05-06 | Lower Price Target | BMO Capital Markets | $77.00 to $74.00 | |
| 2014-05-01 | Reiterated Rating | FBR & Co. | Outperform | $82.00 |
| 2014-05-01 | Reiterated Rating | Deutsche Bank | Hold | $76.00 |
| 2014-05-01 | Reiterated Rating | Leerink Swann | Outperform | $80.00 |
| 2014-05-01 | Reiterated Rating | Citigroup Inc. | Buy | $84.00 |
| 2014-05-01 | Reiterated Rating | JPMorgan Chase & Co. | Overweight | $83.00 |
| 2014-05-01 | Lower Price Target | Maxim Group | Buy | $92.00 to $90.00 |
| 2014-04-30 | Reiterated Rating | Raymond James | Outperform | $76.00 |
| 2014-04-30 | Lower Price Target | Mizuho | Buy | $86.00 to $82.00 |
| 2014-04-30 | Lower Price Target | Cowen and Company | $85.00 to $79.00 | |
| 2014-04-10 | Lower Price Target | Evercore ISI | $77.50 to $75.00 | |
| 2014-03-31 | Boost Price Target | Jefferies Group | $84.00 to $86.00 | |
| 2014-03-06 | Reiterated Rating | Deutsche Bank | Hold | $75.00 to $79.00 |
| 2014-03-05 | Initiated Coverage | Barclays | Overweight | $85.00 |
| 2014-03-05 | Boost Price Target | RBC Capital | Outperform | $72.00 to $84.00 |
| 2014-02-26 | Boost Price Target | BMO Capital Markets | $62.00 to $77.00 | |
| 2014-02-24 | Reiterated Rating | Morgan Stanley | Overweight | $76.00 to $81.00 |
| 2014-02-24 | Boost Price Target | Jefferies Group | Buy | $74.00 to $84.00 |
| 2014-02-21 | Boost Price Target | FBR & Co. | Outperform | $75.00 to $83.00 |
| 2014-02-19 | Boost Price Target | Maxim Group | Buy | $80.00 to $92.00 |
| 2014-02-19 | Upgrade | Monness Crespi & Hardt | Neutral to Buy | |
| 2014-02-18 | Downgrade | Monness Crespi & Hardt | Buy to Neutral | $78.00 |
| 2014-02-18 | Initiated Coverage | Citigroup Inc. | Buy | |
| 2014-01-17 | Boost Price Target | Credit Suisse | $75.00 to $83.00 | |
| 2014-01-17 | Boost Price Target | Mizuho | Buy | $74.00 to $86.00 |
| 2013-12-17 | Boost Price Target | Goldman Sachs | $75.00 to $77.00 | |
| 2013-12-13 | Reiterated Rating | Morgan Stanley | Positive | $70.00 |
| 2013-11-20 | Initiated Coverage | Deutsche Bank | Hold | $73.00 |
| 2013-10-24 | Initiated Coverage | FBR & Co. | Outperform | $75.00 |
| 2013-07-05 | Reiterated | Mizuho | Buy | $63 to $69 |
| 2013-07-01 | Initiated | Monness Crespi & Hardt | Buy | $78 |
| 2013-06-06 | Reiterated | Maxim Group | Buy | $70 to $80 |
| 2013-02-20 | Reiterated | Mizuho | Buy | $60 to $63 |
| 2013-02-19 | Reiterated | ISI Group | Neutral | $57.50 to $58.50 |
| 2013-01-09 | Reiterated | Mizuho | Buy | $62 to $60 |
| 2016-07-04 | Reiterated Rating | Jefferies Group | Buy | |
| 2016-06-27 | Reiterated Rating | Credit Suisse | Buy | |
| 2016-06-27 | Reiterated Rating | Credit Suisse Group AG | Buy | |
| 2016-06-20 | Downgrade | Morgan Stanley | Equal Weight to Underweight | $67.00 to $70.00 |
| 2016-06-16 | Initiated Coverage | Sanford C. Bernstein | Underperform | $68.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In ESRX 101 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| BlackRock Institutional Trust Company, N.A. | 17.47M |
| BlackRock Fund Advisors | 9.12M |
| BlackRock Group LTD | 6.08M |
| Numeric Investors LLC | 2.80M |
| MANAGED ACCOUNT ADVISORS LLC | 2.14M |
| MANNING & NAPIER ADVISORS LLC | 2.06M |
| BlackRock Investment Management, LLC | 1.36M |
| EQUITY INVESTMENT CORP/GA | 1.36M |
| RUSSELL FRANK CO/ | 1.13M |
| BlackRock Japan Co. Ltd | 1.05M |
| BAIRD ROBERT W & CO INC /WI/ | 0.97M |
| PEAK6 Investments, L.P. | 0.85M |
| BLACKROCK ADVISORS LLC | 0.74M |
| EverPoint Asset Management, LLC | 0.70M |
| Placemark Investments, Inc. | 0.55M |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| PAZ GEORGE President, Chairman & CEO | 119.09% (887736) | ESRX / HON / PRU / |
| WENTWORTH TIMOTHY C President | 25.30% (188600) | ESRX / |
| Houston Christine Sr. VP, Operations | 13.15% (98009) | ESRX / |
| Hall Jeffrey EVP & Chief Financial Officer | 12.17% (90737) | ESRX / SEMI / SPLS / |
| Wade Sara E Sr. VP, Ch. Human Res. Off. | 10.61% (79057) | ESRX / |
| IGNACZAK EDWARD B EVP, Sales & Marketijng | 9.32% (69513) | ESRX / |
| Miller Steven B Sr. VP & Chief Med. Officer | 8.59% (64062) | ESRX / |
| MAC MAHON THOMAS P | 8.32% (62044) | ESRX / PMC / |
| HAVEL JAMES M Exec. VP and Interim CFO | 7.76% (57833) | EFSC / ESRX / |
| Queller David A Sr. VP, Sales and Account Mgmt | 7.08% (52799) | ESRX / |
| Akins Martin P. Senior VP & General Counsel | 6.57% (48983) | ESRX / |
| BENANAV GARY G | 6.31% (47028) | B / ESRX / |
| Stettin Glen D. Sr. VP, Clin. Res. & New Sol. | 6.04% (45009) | ESRX / |
| Sample Neal J. Sr. VP & Ch. Information Off. | 5.78% (43122) | AXP / ESRX / |
| LAHOWCHIC NICHOLAS | 5.24% (39026) | ESRX / |
| Smith Catherine R Exec. VP & CFO | 5.07% (37804) | BAX / ESRX / TGT / |
| SLUSSER ERIC Exec. VP & CFO | 4.99% (37218) | ESRX / GTIV / |
| Ebling Keith J. EVP and General Counsel | 4.99% (37200) | ESRX / XRAY / |
| Mergenthaler Frank | 4.72% (35187) | ESRX / IPG / |
| Harper Matthew D VP & Interim CFO | 4.50% (33547) | ESRX / |
| Seiz Brian Sr. VP, Specialty | 4.36% (32499) | ESRX / |
| Neville Everett | 4.24% (31571) | ESRX / |
| PARKER JOHN O | 3.76% (27994) | ESRX / |
| Breen Maura C | 3.28% (24487) | ESRX / |
| Wimberly Gary Sr. VP & Ch. Information Off. | 2.80% (20885) | ESRX / |
| Anderson Phyllis S. Sr. VP & Ch. Marketing Officer | 2.36% (17609) | ESRX / |
| SKINNER SAMUEL K | 2.24% (16696) | CBOE / ECHO / ESRX / MDAS / NCI / VA / |
| ROPER WILLIAM L | 2.16% (16099) | DVA / ESRX / |
| Phillips Bradley E VP, Controller and CAO | 2.00% (14881) | ESRX / |
| MYERS WOODROW A JR | 1.54% (11500) | ESRX / GHDX / KOOL / LPDX / |
| Norton David A Senior VP, Supply Chain | 1.50% (11160) | ESRX / |
| Fotsch Donald SVP, Pharm. Serv. & Mem. Exp. | 1.43% (10693) | ESRX / |
| DeLaney William J III | 1.26% (9414) | ESRX / SANM / SYY / |
| McNamee Patrick EVP & Chief Operating Officer | 1.03% (7664) | ESRX / HDS / HIIQ / |
| ARLOTTA JOHN CEO, eviCore healthcare | 0.90% (6688) | ESRX / |
| McGinnis Christopher A VP, Controller & Ch. Acct. Off | 0.90% (6675) | ESRX / |
| STERNBERG SEYMOUR | 0.83% (6150) | CIT / ESRX / |
| PALMORE RODERICK A | 0.61% (4563) | CBOE / ESRX / GIS / GT / |
| Knibb Christopher K VP & Chief Accounting Officer | 0.52% (3891) | ESRX / |
| Granger Elder | 0.50% (3705) | DLHC / ESRX / |
UM